Technical Analysis for HRTX - Heron Therapeutics, Inc.

Grade Last Price % Change Price Change
grade D 18.43 -1.71% -0.32
HRTX closed down 1.71 percent on Thursday, June 4, 2020, on 84 percent of normal volume. Its advance stalled at its 200 day moving average, an important long-term support / resistance line. The price action carved out a bearish shooting star candlestick pattern. That may indicate a downside reversal. Look for price to trade beneath the low of the shooting star for confirmation. Due to the stock's strong uptrend, it may remain overbought for a while. So, if you're looking for a reason to sell, don't put too much weight on it being overbought.

Trend Table & Recent Signals

ADX Long Term Intermediate Term Short Term
Strong Down Up Flat
Historical HRTX trend table...

Date Alert Name Type % Chg
200 DMA Resistance Bearish 0.00%
Shooting Star Candlestick Bearish 0.00%
Outside Day Range Expansion 0.00%
Wide Bands Range Expansion 0.00%
Overbought Stochastic Strength 0.00%
NR7 Range Contraction -1.71%
NR7-2 Range Contraction -1.71%
Earnings Movers Other -1.71%
Wide Bands Range Expansion -1.71%
Overbought Stochastic Strength -1.71%

Free Daily (Stock) Chart Reading

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:

Profile

Heron Therapeutics, Inc., a specialty pharmaceutical company, develops product candidates using its proprietary Biochronomer polymer-based drug delivery platform. The company's drug delivery platform is designed to improve the therapeutic profile of injectable pharmaceuticals by converting them from products that should be injected once or twice per day to products that need to be injected once every one or two weeks. Its lead product candidate, Sustol, is developed for the prevention of both acute- and delayed-onset chemotherapy-induced nausea and vomiting for patients undergoing emetogenic chemotherapy. The company was formerly known as A.P. Pharma, Inc. and changed its name to Heron Therapeutics, Inc. in January 2014. Heron Therapeutics, Inc. was founded in 1983 and is headquartered in Redwood City, California.
Medicine Health Pharmaceutical Clinical Medicine Oncology Cancer Treatments Chemotherapy Occupational Safety And Health Antineoplastic Drugs Drug Delivery Injectable Pharmaceuticals

Is HRTX a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 26.81
52 Week Low 9.6
Average Volume 1,010,053
200-Day Moving Average 19.10
50-Day Moving Average 14.93
20-Day Moving Average 16.79
10-Day Moving Average 18.37
Average True Range 0.91
ADX 32.46
+DI 33.22
-DI 13.91
Chandelier Exit (Long, 3 ATRs ) 16.77
Chandelier Exit (Short, 3 ATRs ) 16.42
Upper Bollinger Band 20.18
Lower Bollinger Band 13.40
Percent B (%b) 0.74
BandWidth 40.37
MACD Line 1.09
MACD Signal Line 0.96
MACD Histogram 0.1296
Fundamentals Value
Market Cap 997.76 Million
Num Shares 54.1 Million
EPS -4.15
Price-to-Earnings (P/E) Ratio -4.44
Price-to-Sales 59.70
Price-to-Book 11.60
PEG Ratio -0.17
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 19.75
Resistance 3 (R3) 19.86 19.54 19.53
Resistance 2 (R2) 19.54 19.20 19.48 19.45
Resistance 1 (R1) 18.99 19.00 18.82 18.87 19.38
Pivot Point 18.66 18.66 18.58 18.60 18.66
Support 1 (S1) 18.11 18.33 17.95 17.99 17.48
Support 2 (S2) 17.79 18.12 17.73 17.41
Support 3 (S3) 17.23 17.79 17.33
Support 4 (S4) 17.11